Media Coverage

The UK’s Food Standards Agency (FSA) has released a list of cannabinoid (CBD) products which can be sold to consumers, becoming the first country globally to regulate the market for orally consumed, safe legal cannabis extracts.

THE UK has become the first country in the world to regulate the market for safe, orally consumed legal cannabis extracts, following the release today of the Food Standards Agency’s public list of cannabinoid (CBD) products permitted for sale to consumers.

The number of CBD products still in the running for full authorization in the UK has expanded following an announcement that 70 applications covering a total of 3,536 products were advanced by the Food Standards Agency (FSA).

The UK’s food safety watchdog the Food Standards Agency (FSA) has published the first list of CBD – or cannabis-based – food products which are expected to be authorised for sale in the UK.

The UK’s Food Standards Agency on March 31 published a list of CBD products permitted for sale to consumers while the FSA begins a full risk assessment of the products.

Only the CBD products featured on the list may stay on the market. Products not included must be removed from shelves.

Producers of food and drink products containing cannabidiol (CBD) have been provided with clarity over the future legality of their products on the UK market.

The United Kingdom has moved quicker than the United States on regulating cannabinoid (CBD) in foods, beverages and dietary supplements.

The list of credible CBD products is now “one step closer to being authorised” as the FSA announces the next steps in regulating the UK CBD market.

The FSA has today published its anticipated list of credible Novel Food applications, but what do you need to know as a CBD consumer in the UK?

A new commission for the United Kingdom (UK), the Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry, will analyze its current legal cannabis industry and make recommendations on how to best maximize its growth, consumer satisfaction, and competitive potential on a global scale.

A new commission has been set up by The Centre for Medicinal Cannabis (CMC), the Association for the Cannabinoid Industry (ACI) and First November Group to review the legal cannabis industry in the UK.

Some of the UK’s leading cannabinoid industry groups have announced a new commission to review the regulations and policies relating to the country’s legal cannabis industry.

“The FSA has put in a tremendous amount of work to assess the many applications made, including the super-dossier submitted by ACI on behalf of our members,” said Steve Moore, Founder of ACI.

ACI rejects concerns over the future of the UK’s hemp industry after alliances accused a recent government CBD report of excluding crop producers in favour of pharmaceutical and research laboratory businesses.

Up to 40 CBD (cannabinoid) companies have been contacted by the UK Food Standards Agency (FSA) and told they have until 28 February to provide sufficient toxicology data or risk their products being removed from sale.

Participants in the UK’s CBD sector are on stand-by as they await the long-anticipated publication of the Food Standards Agency’s (FSA) list of approved CBD products. The list represents the biggest shake-up to date in the still-young industry.

The U.K.’s Food Standards Agency (FSA) is expected to release a public list of cannabinoid (CBD) products permitted for sale to consumers. Only products on the list will be able to stay on the market, while those not included will need to be removed.

CBD stakeholders in the UK are anticipating the release of a list of compliant products from food safety authorities expected any day as they look to gain footholds in the world’s second-biggest CBD market.

The UK’s Advisory Council on the Misuse of Drugs (ACMD) has made a list of recommendations to UK government on how to regulate the country’s growing CBD sector.

This article covers the CBD situation in Scotland and how it differs from England. Includes quotes from ACI founder Steve Moore and ACI member British Cannabis.

The Grocer dives deep into the UK CBD industry. They feature ACI, our consumer intelligence partner Kantar and three of our members. Free registration required to read the full article.

The latest issue of Hemp Today features an interview with ACI’s Pharmacy Lead, Dr Andy Yates. Andy discusses how the UK’s CBD industry has quietly grown and how the time is right for the government to act to ensure the UK is a world leader in this sector (see page 56).

Many factors have held back CBD as ingredient in mainstream food and drink products. What will the market look like when these challenges recede? Food Navigator catches up with ACI’s Dr Parveen Bhatarah and Laura Williamson.

France 24 reports on Britain’s legal cannabis market which has boomed during the coronavirus pandemic to become the second biggest after the United States, as consumers rushed to alleviate Covid-linked symptoms, industry experts say.

ACI’s Dr Parveen Bhatarah explores explore the future of CBD and other non-psychotropic cannabinoids and cannabimimetics in a co-authored article with Dr Robert Verkerk and Dr Ignazio Garaguso.

Interview with Dr Andy Yates, ACI Pharmacy Associate. Andy has more than 15 years’ pharma experience in medical, commercial, business development and strategy.

Politics.co.uk caught up with ACI co-founder Steve Moore to discuss how UK can lead the world in CBD and cannabis.

Food Navigator look into upcoming innovative CBD products. They highlight results of our recent regulatory successes and market study.

Rainbow’s Cofounder Ludovic Rachou, who is also a founding member of the Association for the Cannabinoid Industry (under the company name Kaya), expressed his trust in the new funding’s ability to get the startup closer to its goal.

Food Manufacturer reports on the opening of our Brussels office to allow us to continue working with partners on the continent to provide bespoke regulatory and compliance services, such as assisting with novel food applications to EFSA and lobbying efforts on behalf of our members within the European institutions.

Following an engaging discussion between three CBD experts brought to you by New Food, they revisit the trio as they answer some of the unanswered questions posed during the session. Featuring Chris Stubbs of GenCanna, Nathan Wogman of Taylor Mammon and ACI’s Shomi Malik.

BBC ran a 6 minute look at the UK CBD market. It features ACI’s Dr Parveen Bhatarah.

It is available on iPlayer and can been seen from 7 mins 17 seconds.

Speaking to NutritionInsight, Dr. Parveen Bhatarah, regulatory and compliance director for UK’s ACI, discloses that the testing and sharing of different measurement methods will be “invaluable information” for determining the UK industry’s capability in analyzing CBD products.

The UK has the world’s most developed regulatory framework for legal cannabinoids. With a 2021 market estimated to be worth £690 million (€800M) it is the second largest in the world after the US. In this free white paper you’ll learn the requirements to enter this lucrative market.

Dutch – Het stelt de ACI in staat om Europese bedrijven te helpen die de lucratieve Britse markt willen betreden, terwijl ze tegelijkertijd een platform bieden voor samenwerking met de Europese regelgevende instanties.

This European expansion coincides with a further strengthening of the ACI team, adding a wealth of experience in the European legal cannabinoid extract supply chain.

Hemp Today takes a closer look at ACI’s new membership offering and explores how we can help business gain access to the lucrative UK market.

Even the coronavirus pandemic couldn’t stop the UK cannabis market to keep growing as a new report claims that the UK has the world’s second largest CBD market behind the US.

With brand new CBD regulations coming into force this year and an array of products hitting the market, Speciality Food put CBD food and drink under the microscope.